DIGITAL EDITION
GO TO CURRENT ISSUE - FREE!
> BUY > SUBSCRIBE > ARCHIVES  

JUNE 2014 • Contents

> GO TO THE TABLE OF CONTENTS

NOTE: The content below contains the first few paragraphs of the printed article and the titles of the sidebars and boxes, if applicable.
Request Reprint Quote
Purchase Back Issue
Purchase PDF

PharmaVOICE
- January 2014

Innovation Incubators
By Robin Robinson

    In November 2013, Wellspring Biosciences discovered small molecules that bind irreversibly to a common oncogenic mutant, K-Ras G12C, one of the most promising approaches to target K-Ras yet reported.  The finding was facilitated by Wellspring’s participation in Janssen Labs’ incubator program at its West Coast Research Center, which provides a capital-efficient, resource-rich environment for independent emerging companies to progress their research. Within this innovative environment, Wellspring was able to achieve this discovery in a matter of months...

Sidebars:
Innovation Incubators

WHAT’S THIS?
PDF:
Single-user watermarked PDF file. Copyright protected for your review only. This file cannot be used as a promotional or educational piece. If you are interested in an E-Print, request a Reprint Quote for pricing.
*Downloaded PDF files are not returnable or refundable.
Reprint:
A hard-copy reproduction of a specific article printed for promotional or educational use. These are printed in quantities of 100 to 2,500.
Back Issue:
A printed copy of an entire magazine. These are sold in unlimited quantities.


 

HBA Leadership

WebSeminars - Register Today!

PharmaVOICEMarketplace - Directory of Service Providers

 
close

Advertisement